Literature DB >> 29404169

Ranitidine-Induced Anaphylaxis in a Patient with Acute COPD Exacerbation.

İnsu Yılmaz1, Murat Türk1.   

Abstract

Ranitidine is a well-tolerated H2-receptor antagonist commonly used in peptic ulcer treatment and stress ulcer prophylaxis. Anaphylaxis is rarely observed with ranitidine. We report the case of a patient who developed anaphylaxis after intravenous injection of ranitidine for acute COPD exacerbation. This article underlines the importance of awareness that in COPD acute exacerbation treatment, ranitidine, which is usually administered with methylprednisolone, also has anaphylaxis potential.

Entities:  

Keywords:  Drug allergy; anaphylaxis; ranitidine

Year:  2017        PMID: 29404169      PMCID: PMC5783089          DOI: 10.5152/TurkThoracJ.2017.17002

Source DB:  PubMed          Journal:  Turk Thorac J        ISSN: 2148-7197


  10 in total

1.  Cross-allergy to ranitidine and nizatidine.

Authors:  M Morisset; D A Moneret-Vautrin; V Loppinet; S Grandidier
Journal:  Allergy       Date:  2000-07       Impact factor: 13.146

2.  Side-effects, structure, and H2-receptor antagonists.

Authors:  A Bossi; G Romeo; A Pezzoli
Journal:  Lancet       Date:  1992-05-30       Impact factor: 79.321

3.  Ranitidine-induced anaphylaxis: detection of serum specific IgE antibody.

Authors:  Y I Koh; H-S Park; I S Choi
Journal:  Allergy       Date:  2006-02       Impact factor: 13.146

Review 4.  The safety of ranitidine in over a decade of use.

Authors:  J G Mills; K M Koch; C Webster; M A Sirgo; K Fitzgerald; J R Wood
Journal:  Aliment Pharmacol Ther       Date:  1997-02       Impact factor: 8.171

Review 5.  Severe ranitidine-induced anaphylaxis: a case report and literature review.

Authors:  K Aouam; W Bouida; N Ben Fredj; A Chaabane; H Boubaker; R Boukef; N A Boughattas; S Nouira
Journal:  J Clin Pharm Ther       Date:  2011-11-07       Impact factor: 2.512

Review 6.  Anaphylactic reaction to drugs commonly used for gastrointestinal system diseases: 3 case reports and review of the literature.

Authors:  K Demirkan; B Bozkurt; G Karakaya; A F Kalyoncu
Journal:  J Investig Allergol Clin Immunol       Date:  2006       Impact factor: 4.333

7.  A case of famotidine-induced anaphylaxis.

Authors:  Y I Kim; C K Park; D J Park; J O Wi; E R Han; Y I Koh
Journal:  J Investig Allergol Clin Immunol       Date:  2010       Impact factor: 4.333

8.  Ranitidine-induced anaphylaxis: clinical features, cross-reactivity, and skin testing.

Authors:  K H Park; J Pai; D-G Song; D W Sim; H J Park; J-H Lee; K Y Jeong; C-H Pan; I Shin; J-W Park
Journal:  Clin Exp Allergy       Date:  2016-04       Impact factor: 5.018

9.  Anaphylactic reaction to ranitidine (Zantac®).

Authors:  Tae Young Han; Woo Sun Jang; Mi Yu; Hyun Kyung Lee; Sook-Ja Son; Seong Jun Seo
Journal:  Int J Dermatol       Date:  2011-11       Impact factor: 3.204

10.  Ranitidine-induced perioperative anaphylaxis: A rare occurrence and successful management.

Authors:  Shekhar Neema; Subrato Sen; Manas Chatterjee
Journal:  Indian J Pharmacol       Date:  2016 Mar-Apr       Impact factor: 1.200

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.